MedPath

PULMOSIRUM PLUS EXPECTORANT

PULMOSIRUM PLUS EXPECTORANT

Discontinued
DIN Number

00805599

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

nutribon (1986) inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00805599
AIG Number1144641001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CA10 COMBINATIONS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:16.00
Health Canada Classification

ACTIVE INGREDIENTS (11)

AMMONIUM CHLORIDEActive
Strength: 5 MG / ML
Monograph: AMMONIUM CHLORIDE
BEECHWOOD CREOSOTEActive
Strength: 6 MCG / ML
Monograph: BEECHWOOD CREOSOTE
COCILLANAActive
Strength: 16.8 MG / ML
Monograph: COCILLANA
EUCALYPTUS OILActive
Strength: .03 MG / ML
Monograph: EUCALYPTUS OIL
GUAIACOLActive
Strength: .01 MG / ML
Monograph: GUAIACOL
GUAIFENESINActive
Strength: 5 MG / ML
Monograph: GUAIFENESIN
IPECACActive
Strength: .12 MG / ML
Monograph: IPECAC
LOBELIA INFLATAActive
Strength: .06 MG / ML
Monograph: LOBELIA INFLATA
MENTHOLActive
Strength: .8 MG / ML
Monograph: MENTHOL
MYROXYLON BALSAMUMActive
Strength: .2 MG / ML
Monograph: MYROXYLON BALSAMUM
WHITE PINEActive
Strength: 50 MG / ML
Monograph: WHITE PINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.